# Itron, Inc.: overview ITRI · Nasdaq · CIK 780571 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/itri.md) · [Financials](/companies/itri/financials.md) · [Filings](/companies/itri/filings.md) · [Insiders](/companies/itri/insiders.md) Latest reported revenue: [$599.3m](/filings/0000780571-26-000233.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 27, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000780571-26-000233). ## Last eight quarters | Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [613 d](/filings/0000780571-26-000033.md) | [607](/filings/0000780571-26-000110.md) | [607](/filings/0000780571-26-000178.md) | [582](/filings/0000780571-26-000233.md) | [572 d](/filings/0000780571-26-000033.md) | [587](/filings/0000780571-26-000110.md) | [563](/filings/0000780571-26-000178.md) | [599](/filings/0000780571-26-000233.md) | | Gross margin | % | [34.9% d](/filings/0000780571-26-000033.md) | [35.8%](/filings/0000780571-26-000110.md) | [36.9%](/filings/0000780571-26-000178.md) | [37.7%](/filings/0000780571-26-000233.md) | [40.5% d](/filings/0000780571-26-000033.md) | [40.3%](/filings/0000780571-26-000110.md) | [41.0%](/filings/0000780571-26-000178.md) | [40.9%](/filings/0000780571-26-000233.md) | | Operating margin | % | [10.2% d](/filings/0000780571-26-000033.md) | [12.6%](/filings/0000780571-26-000110.md) | [12.6%](/filings/0000780571-26-000178.md) | [14.1%](/filings/0000780571-26-000233.md) | [13.8% d](/filings/0000780571-26-000033.md) | [11.5%](/filings/0000780571-26-000110.md) | [13.5%](/filings/0000780571-26-000178.md) | [15.9%](/filings/0000780571-26-000233.md) | | Net margin | % | [9.5% d](/filings/0000780571-26-000033.md) | [10.8%](/filings/0000780571-26-000110.md) | [11.3%](/filings/0000780571-26-000178.md) | [11.3%](/filings/0000780571-26-000233.md) | [17.8% d](/filings/0000780571-26-000033.md) | [9.1%](/filings/0000780571-26-000110.md) | [9.5%](/filings/0000780571-26-000178.md) | [11.9%](/filings/0000780571-26-000233.md) | | Diluted EPS | $ per share | not reported | [1.42](/filings/0000780571-26-000110.md) | [1.47](/filings/0000780571-26-000178.md) | [1.41](/filings/0000780571-26-000233.md) | not reported | [1.18](/filings/0000780571-26-000110.md) | [1.19](/filings/0000780571-26-000178.md) | [1.61](/filings/0000780571-26-000233.md) | | Free cash flow | $m | [70.2 d](/filings/0000780571-26-000033.md) | [67.5](/filings/0000780571-26-000110.md) | [90.7 d](/filings/0000780571-26-000178.md) | [113 d](/filings/0000780571-26-000233.md) | [112 d](/filings/0000780571-26-000033.md) | [79.0](/filings/0000780571-26-000110.md) | [81.5 d](/filings/0000780571-26-000178.md) | [95.5 d](/filings/0000780571-26-000233.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [1,982](/filings/0000780571-24-000006.md) | [1,796](/filings/0000780571-25-000007.md) | [2,174](/filings/0000780571-26-000033.md) | [2,441](/filings/0000780571-26-000033.md) | [2,367](/filings/0000780571-26-000033.md) | | Gross margin | % | [28.9%](/filings/0000780571-24-000006.md) | [29.1%](/filings/0000780571-25-000007.md) | [32.8%](/filings/0000780571-26-000033.md) | [34.4%](/filings/0000780571-26-000033.md) | [37.7%](/filings/0000780571-26-000033.md) | | Operating margin | % | [(4.0%)](/filings/0000780571-24-000006.md) | [(0.4%)](/filings/0000780571-25-000007.md) | [5.9%](/filings/0000780571-26-000033.md) | [10.8%](/filings/0000780571-26-000033.md) | [13.2%](/filings/0000780571-26-000033.md) | | Net margin | % | [(4.1%)](/filings/0000780571-24-000006.md) | [(0.5%)](/filings/0000780571-25-000007.md) | [4.5%](/filings/0000780571-26-000033.md) | [9.8%](/filings/0000780571-26-000033.md) | [12.7%](/filings/0000780571-26-000033.md) | | Diluted EPS | $ per share | [(1.83)](/filings/0000780571-24-000006.md) | [(0.22)](/filings/0000780571-25-000007.md) | [2.11](/filings/0000780571-26-000033.md) | [5.18](/filings/0000780571-26-000033.md) | [6.50](/filings/0000780571-26-000033.md) | | Free cash flow | $m | [120](/filings/0000780571-24-000006.md) | [4.8](/filings/0000780571-25-000007.md) | [98.1](/filings/0000780571-26-000033.md) | [208](/filings/0000780571-26-000033.md) | [383](/filings/0000780571-26-000033.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/itri/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $617.1m | 7,131,562 | | Reduced −18,183 | | [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $302.7m | 3,497,943 | | Reduced −8,724 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $173.1m | 2,000,004 | | Reduced −14,116 | | [Impax Asset Management Group plc](/funds/1749768.md) | 2026-06-30 | $166.7m | 1,926,905 | | Reduced −266,243 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $156.6m | 1,810,117 | | Added +4,437 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $153.0m | 1,768,271 | | Added +232,190 | | [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $132.5m | 1,531,300 | | Reduced −69,266 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $107.5m | 1,242,308 | | Added +56,202 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $106.2m | 1,226,800 | Call | Unchanged | | [FIRST TRUST ADVISORS LP](/funds/1125816.md) | 2026-06-30 | $105.1m | 1,214,181 | | Added +244,953 | ## Recent filings [All 1,932 filings](/companies/itri/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-27 | 12:46 ET | [10-Q](/filings/0000780571-26-000233.md) | Quarterly report, period 2026-09-30 | 0000780571-26-000233 | | 2026-10-27 | 08:35 ET | [8-K](/filings/0001171843-26-006839.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-006839 | | 2026-07-28 | 13:43 ET | [10-Q](/filings/0000780571-26-000178.md) | Quarterly report, period 2026-06-30 | 0000780571-26-000178 | | 2026-07-28 | 08:35 ET | [8-K](/filings/0001171843-26-004912.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-004912 | | 2026-05-08 | 17:58 ET | [8-K](/filings/0000780571-26-000116.md) | 5.07 Shareholder vote results; 8.01 Other events | 0000780571-26-000116 | | 2026-05-01 | 08:30 ET | [8-K/A](/filings/0001193125-26-199316.md) | 8.01 Other events | 0001193125-26-199316 | | 2026-04-28 | 13:11 ET | [10-Q](/filings/0000780571-26-000110.md) | Quarterly report, period 2026-03-31 | 0000780571-26-000110 | | 2026-04-28 | 08:35 ET | [8-K](/filings/0001171843-26-002750.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-002750 | | 2026-04-24 | 08:30 ET | [8-K](/filings/0001193125-26-175249.md) | 8.01 Other events | 0001193125-26-175249 | | 2026-03-23 | 12:36 ET | [DEF 14A](/filings/0001140361-26-010703.md) | Proxy statement, period 2026-05-07 | 0001140361-26-010703 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000780571-26-000033.md), filed Feb 17, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, has been scored from the reported figures. [See the target](/leagues/2026q3/targets/826eab3a-0b40-4f90-b366-f001a35723da) ## About the filer - CIK: 780571 - Tickers: ITRI - Exchange: Nasdaq - SIC code: 3825 Instruments For Meas & Testing of Electricity & Elec Signals - State of incorporation: WA - Filer category: Large accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 12:53 ET. No prices; not investment advice.